Tailoring Pelvic Lymphadenectomy for Patients with Stage IA2, IB1, and IIA1 Uterine Cervical Cancer
Open Access
- 1 January 2015
- journal article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 6 (4) , 377-381
Abstract
The purpose of this study was to assess the risk factors for pelvic lymph node metastasis (PLNM) in patients with early-stage uterine cervical cancer.A total of 192 patients with early-stage uterine cervical cancer (FIGO stage IA2, IB1, and IIA1) receiving radical hysterectomy with pelvic lymphadenectomy were included in the statistical analysis.Thirty-six patients (18.8%) developed PLNM, and the incidences of PLNM in patients with stage IA2, stage IB2, and stage IIA1 were 0% (0/6), 13.9% (20/144), and 38.1% (16/42), respectively. The most common location of PLNM was the obturator lymph node. Univariate analysis showed that stage IIA1 (p < 0.001), tumor size greater than 3 cm (p = 0.019), deep-full thickness stromal invasion (p < 0.001), and lymphovascular invasion (p = 0.001) were associated with PLNM. Multivariate analysis showed that deep or full-thickness stromal invasion and lymphovascular invasion were significantly and independently associated with PLNM (p < 0.05 for both). The incidence of PLNM was 34.9% and 28.7% in patients with deep-full thickness stromal invasion and lymphovascular invasion, respectively, but that was only 5.7% and 9.2% in patients with superficial-middle stromal invasion and absence of lymphovascular invasion, respectively.Patients with superficial-middle stromal invasion and without lymphovascular invasion may be avoided pelvic lymphadenectomy in stage IA2, IB1, IIA1 uterine cervical cancer.Keywords
This publication has 28 references indexed in Scilit:
- The surgical management of early-stage cervical cancerCurrent Opinion in Obstetrics and Gynecology, 2013
- The Role of Lymphadenectomy in Cervical Cancer Patients: The Significance of the Number and the Status of Lymph Nodes Removed in 526 Cases Treated in a Single InstitutionAnnals of Surgical Oncology, 2013
- The incidences and mortalities of major cancers in China, 2009Chinese Journal of Cancer, 2013
- The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology.2013
- Complications of lymphadenectomy for gynecologic cancerEuropean Journal of Surgical Oncology, 2013
- Pelvic node removal and disease‐free survival in cervical cancer patients treated with radical hysterectomy and pelvic lymphadenectomyInternational Journal of Gynecology & Obstetrics, 2011
- Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomyGynecologic Oncology, 2010
- Therapeutic role of lymphadenectomy for cervical cancerCancer, 2010
- Trends in Cervical Cancer Incidence and Mortality in Bulgaria, Estonia, Latvia, Lithuania and RomaniaTumori Journal, 2010
- The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cervical cancerEuropean Journal of Surgical Oncology, 2007